The optimization of processes in the development and manufacturing of biopharmaceuticals is crucial in ensuring the production of high-quality products. This complex process requires meticulous planning and execution to meet product specifications and deliver safe and effective biologic drugs. Contract development and manufacturing organizations (CDMOs) often play a key role in assisting sponsor companies with process development. Let’s delve into the strategies and insights shared by experts and bio/pharma CDMOs on how to optimize process development in the biopharmaceutical industry.
Optimizing Upstream Processes: Scalability and Experimentation
When it comes to optimizing upstream processes, scalability is a critical factor to consider. Daniel Giroux from Abzena emphasizes the need for a scalable production system, especially in large-scale bioreactors ranging from 500 to 2000-L capacities. However, running multiple experiments for optimization in a single large reactor can be challenging. Giroux suggests the use of small-scale systems to replicate growth and production parameters effectively. Utilizing a design-of-experiment (DoE) approach enables the identification of key parameters that impact product quality and titer, leading to optimal process outcomes.
Process Intensification and Media Optimization in Microbial Fermentation
Paul Mugford of BIOVECTRA highlights the importance of media optimization in microbial fermentation to support optimal growth and productivity. Media formulation plays a crucial role in providing essential nutrients for microorganism development. Mugford emphasizes the need for animal-free media components and starting process development with materials that meet GMP requirements for seamless scale-up. Process intensification, aimed at achieving higher cell densities at inoculation, can significantly enhance productivity in fed-batch processes.
Enhancing Viral Vector and Gene Therapy Process Optimization
Bob Schrock from Lonza Group AG stresses the significance of scaling up viral-vector-based gene therapy products while maintaining cell morphology and genetic stability. Key parameters such as Multiplicity of Infection (MOI), plasmid ratios, and transduction amounts need to be carefully optimized to ensure consistent and high-quality virus yields. Maintaining optimal cell yields across different scales is crucial for successful cell therapy outcomes.
Quality Considerations and Regulatory Compliance in Fermentation Processes
Mugford discusses the importance of quality considerations and regulatory guidelines in fermentation processes. Selecting the right microbial strain and plasmid design are crucial steps in optimizing protein production. Engineered E. coli strains and well-designed plasmids can enhance productivity and ensure correct folding of proteins. Ensuring plasmid stability and reducing endonuclease activity are vital for maximizing productivity and maintaining product integrity.
Streamlining Downstream Processing and Harvesting Techniques
Efficient downstream processing is essential for extracting and purifying biopharmaceutical products. Giroux recommends continuous centrifugation as a superior method for cell harvesting due to its high yield and minimal liquid loss. Choosing the right scale-down equipment is crucial for generating representative materials for downstream processing steps. Mugford highlights the use of tangential flow filtration (TFF) for plasmid DNA harvesting, which offers a cleaner product for downstream processing.
Leveraging Automation and Closed Systems for Process Optimization
Schrock emphasizes the importance of closing open manual process steps to reduce contamination risks and production costs. Process automation for equipment and perfusion plays a vital role in optimizing parameters such as pH, dissolved oxygen, and agitation. Utilizing closed systems like the Lonza Cocoon Instrument can streamline the manufacturing of autologous cell therapies and optimize process parameters effectively.
Takeaways:
- Scalability is crucial in optimizing upstream processes for biopharmaceutical development.
- Media optimization and process intensification play key roles in microbial fermentation.
- Quality considerations and regulatory compliance are essential in fermentation processes.
- Efficient downstream processing techniques, such as continuous centrifugation and TFF, enhance product purity.
- Leveraging automation and closed systems can streamline process optimization and reduce contamination risks.
In conclusion, optimizing biopharmaceutical process development requires a comprehensive approach encompassing upstream, downstream, and quality considerations. Collaborating with CDMOs and leveraging advanced technologies can streamline the complex process of biopharmaceutical production, ensuring the delivery of safe and effective medications to patients worldwide.
Tags: plasmid design, downstream, filtration, formulation, upstream, automation, microbial fermentation, cell therapy, fed batch, regulatory
Read more on pharmtech.com